Evidence map›Paper›PMID 34024545›Full record

ReviewClinical nutrition ESPEN2021

Strengthening the immunity of the Swiss population with micronutrients: A narrative review and call for action.

Mette M Berger, Isabelle Herter-Aeberli, Michael B Zimmermann, Jörg Spieldenner, Manfred Eggersdorfer

Open access · hybridAbstract readReview
In one paragraph

Review in Clinical nutrition ESPEN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Antiviral Potential of Plants against COVID-19 during Outbreaks-An Update.International journal of molecular sciences · 2022
    Review
  8. Observational
  9. Review
  10. Response to Singh and Singh.Nutrition & diabetes · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Putative Role of Vitamin D for COVID-19 Vaccination.International journal of molecular sciences · 2021
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Mette M BergerLausanne University Hospital (CHUV) & University of Lausanne, Lausanne, Switzerland. Electronic address: mette.berger@chuv.ch.
Isabelle Herter-AeberliLaboratory of Human Nutrition, Institute of Food, Nutrition, and Health, ETH Zürich, Zurich, Switzerland. Electronic address: isabelle.herter@hest.ethz.ch.
Michael B ZimmermannDepartment of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland. Electronic address: michael.zimmermann@hest.ethz.ch.
Jörg SpieldennerInnosuisse, Bern, Switzerland. Electronic address: spieldenner@gmx.net.
Manfred EggersdorferDepartment of Internal Medicine, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: dr.eggersdorfer@gmail.com.
ETH Zurich · CHBerner Augenklinik am Lindenhofspital · CHUniversity Hospital of Lausanne · CHUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe enormous health impact of the COVID-19 pandemic has refocused attention on measures to optimize immune function and vaccine response. Dietary deficiencies of micronutrients can weaken adaptive immunity. The aim of this review was to examine links between micronutrients, immune function and COVID-19 infection, with a focus on nutritional risks in subgroups of the Swiss population.

methodsScoping review on the associations between selected micronutrients (vitamins D and C, iron, selenium, zinc, and n-3 PUFAs) and immunity, with particular reference to the Swiss population. These nutrients were chosen because previous EFSA reviews have concluded they play a key role in immunity.

resultsThe review discusses the available knowledge on links between sufficient nutrient status, optimal immune function, and prevention of respiratory tract infections. Because of the rapid spread of the COVID-19 pandemic, controlled intervention studies of micronutrients in the context of COVID-19 infection are now underway, but evidence is not yet available to draw conclusions. The anti-inflammatory properties of n-3 PUFAs are well established. In Switzerland, several subgroups of the population are at clear risk of nutrient deficiencies; e.g., older adults, multiple comorbidities, obesity, pregnancy, and institutionalized. Low intakes of n-3 PUFA are present in a large proportion of the population.

conclusionThere are clear and strong relationships between micronutrient and n-3 PUFA status and immune function, and subgroups of the Swiss population are at risk for deficient intakes. Therefore, during the COVID-19 pandemic, as a complement to a healthy and balanced diet, it may be prudent to consider supplementation with a combination of moderate doses of Vitamins C and D, as well as of Se, Zn and n-3 PUFA, in risk groups.

Indexed as

COVID-19 Drug TreatmentDietary SupplementsAnti-Inflammatory AgentsAscorbic AcidComorbidityCOVID-19Fatty Acids, Omega-3FemaleHumansImmunologic FactorsMaleMicronutrientsNutritional StatusPandemicsPregnancySARS-CoV-2Anti-Inflammatory AgentsAscorbic AcidFatty Acids, Omega-3Immunologic FactorsMicronutrientsSeleniumTrace ElementsVitamin DVitaminsZincDeficiencyImmunityIronNutritionSeleniumVitamin DZinc n-3 PUFA

Identifiers

PMID34024545
PMCPMC7987506
OpenAlexW3137524664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.